Diagnostics, treatment, and follow-up in craniopharyngioma

Frontiers in Endocrinology

Volumn 2, Issue NOV, 2011, Pages

  Müller, Hermann L ^a  

^a KLINIKUM OLDENBURG   (Germany)

Author keywords

Brain tumors; Craniopharyngioma; Hypothalamus; Irradiation; Neurosurgery; Obesity; Pituitary; Quality of life

Indexed keywords

EID: 84874388485     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2011.00070     Document Type: Review

References (74)

1. Attanasio, A. F., Bates, P. C., Ho, K. K., Webb, S. M., Ross, R. J., Stras-burger, C. J., Bouillon, R., Crowe, B., Selander, K., Valle, D., and Lamberts, S. W. (2002). Human growth hormone replacement in adult hypopi-tuitary patients: long-term effects on body composition and lipid status-3-year results from the HypoCCS Database. J. Clin. Endocrinol Metab. 87,1600-1606.
2. Baumert, B. G., Norton, I. A., Lomax, A. J., and Davis, J. B. (2004). Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions. Int. J. Radiat. Oncol. Biol. Phys. 60, 1314-1324.
3. Becker, G., Kortmann, R.-D., Skalej, M., and Bamberg, M. (1999). "The role of radiotherapy in the treatment of craniopharyngeoma - indications, results, side effects," in Controversies in Neuro-Oncology, eds T. Wiegel, T. Hinkelbein, M. Brock, and T. Hoell (Basel: Karger) 33,100-113.
4. Boop,F.A. (2007). Craniopharyngioma. J. Neurosurg. 106, 1-2.
5. Bunin, G. R., Surawicz, T. S., Wit-man, P. A., Preston-Martin, S., Davis, E, and Bruner, J. M. (1998). The descriptive epidemiology of craniopharyngioma. J. Neurosurg. 89, 547-551.
6. Choux, M., Lena, G., and Genitori, L. (1991). Craniopharyngioma in children. Neurochirurgie 37 (Suppl. 1), 1-174.
7. DeVile, C. J., Grant, D. B., Hayward, R. D., and Stanhope, R. (1996a). Growth and endocrine sequelae of craniopharyngioma. Arch. Dis. Child. 75, 108-114.
8. DeVile, C. J., Grant, D. B., Hayward, R. D., Kendall, B. E., Neville, B. G. R., and Stanhope, R. (1996b). Obesityin childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J. Clin. Endocrinol. Metab. 81,2734-2737.
9. DeVile, C. J., Grant, D. B., Kendall, B. E., Neville, B. G. R., Stanhope, R., Watkins, K. E., and Hayward, R. D. (1996c). Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J. Neurosurg. 85, 73-81.
10. DiRocco, C., Caldarelli, M., Tambur-rini, G., and Massimi, L. (2006). Surgical management of cran-iopharyngiomas - experience with a pediatric series. J. Pediatr. Endocrinol. Metab. 19(Suppl. 1), 355-366.
11. Einhaus,S.L.,andSanford,R.A. (2007). "Craniopharyngioma," in Principles and Practice of Pediatric Neuro-surgery, eds A. L. Albright, I. E Pollack, and P. D. Adelson (New York, NY: Thieme Medical Publishers), 545-562.
12. Fahlbusch, R., Honegger, J., Paulus, W., Huk, W., and Buchfelder, M. (1999). Surgical management of craniopharyngiomas: experience with 168 patients. J. Neurosurg. 90, 237-250.
13. Fischer, E. G., Welch, K., Shillito, J., Winston, K. R., and Tarbell, N. J. (1990). Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy. J. Neu-rosurg. 73, 534-540.
14. Fisher, P. G., Jenab, J., Goldthwaite, P. T., Tihan, T., Wharam, M. D., Foer, D. R., and Burger, P. C. (1998). Outcomes and failure patterns in childhood craniopharyngiomas. Childs Nerv. Syst. 14, 558-563.
15. Fitzek, M. M., Linggood, R. M., Adams, J., and Munzenrider, J. E. (2006). Combined proton and photon irradiation for craniopharyn-gioma: long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital. Int. J. Radiat Oncol. Biol. Phys. 64, 1348-1354.
16. Garré, M. L., and Cama, A. (2007). Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr. Opin. Pediatr. 19,471-479.
17. Harz, K. J., Müller, H. L., Waldeck, E., Pudel, V., and Roth, C. (2003). Obesity in patients with craniopharyngioma: assessment of physical activity and food intake. J. Clin. Endocrinol. Metab. 88, 5227-5231.
18. Hetelekidis, S., Barnes, P. D., Tao, M. L., Fischer, E. G., Schneider, L., Scott, R. M., and Tarbell, N. J. (1993). 20-year experience in childhood craniopharyngioma. Int. J. Radiat. Oncol. Biol. Phys. 27, 189-195.
19. Hölsken, A., Buchfelder, M., Fahlbusch, R., Blümcke, I., and Buslei, R. (2010). Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling. Acta Neuropathol. 119,631-639.
20. Honegger, J., Buchfelder, M., and Fahlbusch, R. (1999). Surgical resection of craniopharyngiomas: endocrinological results. J. Neurosurg. 90,251-257.
21. Ierardi, D. F., Fernandes, M. J., Silva, I. R., Thomazini-Gouveia, J., Silva, N. S., Dastoli, P., Toledo, S. R., and Cavalheiro, S. (2007). Apoptosis in alpha interferon (IFN-alpha) intra-tumoral chemotherapy for cystic craniopharyngiomas. Childs Nerv. Syst. 23,1041-1046.
22. Kendall-Taylor, P., Jönsson, P. J., Abs, R., Erfurth, E. M., Koltowska-Häggström, M., Price, D. A., and Verhelst, J. (2005). The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur. J. Endocrinol. 152, 557-567.
23. Koranyi, J., Svensson, J., Götherström, G., Sunnerhagen, K. S., Bengtsson, B., and Johannsson, G. (2001). Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study. J. Clin. Endocrinol. Metab. 86, 4693-4639.
24. Lustig, R. H., Hinds, P. S., Ringwald-Smith, K., Christensen, R. K., Kas-ten, S. C., Schreiber, R. E., Rai, S. N., Lensing, S. Y., Wu, S., and Xiong, X. (2003a). Octreotide therapy of pediatric hypothalamic obesity: a doubleblind, placebo-controlled trial. J. Clin. Endocrinol. Metab. 88, 2586-2592.
25. Lustig, R. H., Post, S. R., Srivanna-boon, K., Rose, S. R., Danish, R. K., Burghen, G. A., Xiong, X., Wu, S., and Merchant, T. E. (2003b). Risk factors for the development of obesity in children surviving brain tumours. J. Clin. Endocrinol. Metab. 88,611-616.
26. Luu, Q. T., Loredo, L. N., Archambeau, J. O., Yonemoto, L. T., Slater, J. M., and Slater, J. D. (2006). Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report. Cancer J. 12, 155-159.
27. Mason, P. W., Krawiecki, N., and Meacham, L. R. (2002). The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch. Pediatr. Adolesc. Med. 156, 887-892.
28. Merchant, T. E., Goloubeva, O., Pritchard, D. L., Gaber, M. W., Xiong, X., Danish, R. K., and Lustig, R. H. (2002a). Radiation dose-volume effects on growth hormone secretion. Int. J. Radiat. Oncol. Biol. Phys. 52,1264-1270.
29. Merchant, T. E., Kiehna, E. N., San-ford, R. A., Mulhern, R. K., Thompson, S. J., Wilson, M. W., Lustig, R. H., and Kun, L. E. (2002b). Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984-2001. Int. J. Radiat. Oncol. Biol. Phys. 53, 533-542.
30. Merchant, T. E., Kiehna, E. N., Kun, L. E., Mulhern, R. K., Li, C., Xiong, X., Boop, F. A., and Sanford, R. A. (2006). Phase II trial of con-formal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J. Neurosurg. 104, 94-102.
31. Moon, S. H., Kim, I. H., Park, S.W., Kim, I., Hong, S., Park, C. I., Wang, K. C.,and Cho, B. K. (2005). Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas - a study in single institute. Childs Nerv. Syst. 21, 799-807.
32. Müller, H. L. (2006). More or less -treatment strategies in childhood craniopharyngioma. Childs Nerv. Syst. 22, 156-157.
33. Müller, H. L. (2010). Childhood craniopharyngioma - current concepts in diagnosis, therapy and follow-up. Nat. Rev. Endocrinol. 6, 609-618.
34. Müller, H. L. (2011). Consequences after craniopharyngioma surgery in children. J. Clin. Endocrinol. Metab. 96,1981-1991.
35. Müller, H. L., Albanese, A., Calami-nus, G., Hargrave, D., Garré, M. L., Gebhardt, U., Saran, F., Sörensen, N., and Spoudeas, H. A. (2006a). Consensus and perspectives on treatment strategies in childhood craniopharyngioma - results of a meeting of the craniopharyngioma study group (SIOP), Genova 2004. J. Pediatr. Endocrinol. Metab. 19, 453-454.
36. Müller, H. L., Gebhardt, U., Pohl, F., Flentje, M., Emser, A., Warmuth-Metz, M., Kolb, R., Calaminus, G., and Sörensen, N. (2006b). Relapse pattern after complete resection and early progressions after incomplete resection of childhood craniopharyngioma - update on KRAN-IOPHARYNGEOM 2000 and design of KRANIOPHARYNGEOM 2007. Klin. Padiatr. 218, 315-320.
37. Müller, H. L., Handwerker, G., Gebhardt, U., Faldum, A., Emser, A., Kolb, R., and Sörensen, N. (2006c). Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness. Cancer Causes Control 17, 583-589.
38. Müller, H. L., Müller-Stöver, S., Gebhardt, U., Kolb, R., Sörensen, N., and Handwerker, G. (2006d). Secondary narcolepsy may be an underrated cause of increased daytime sleepiness in obese patients after childhood craniopharyngioma. J. Pediatr. Endocrinol. Metab. 19, 423-429.
39. Müller, H. L., Bruhnken, G., Emser, A., Faldum,A.,Etavard-Gorris,N., Gebhardt, U., Kolb, R., and Sörensen, N. (2005a). Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma. ChildsNerv. Syst. 21, 975-980.
40. Müller, H. L., Gebhardt, U., Faldum, A., Emser, A., Etavard-Gorris, N., Kolb, R., and Sörensen, N. (2005b). Functional capacity and body mass index in patients with sellar masses - cross-sectional study on 403 patients diagnosed during childhood and adolescence. ChildsNerv. Syst. 21,539-545.
41. Müller, H. L., Bueb, K., Bartels, U., Roth, C., Harz, K., Graf, N., Korinthenberg, R., Bettendorf, M., Kühl, J., Gut-jahr, P., Sörensen, N., and Calaminus, G. (2001). Obesity after childhood craniopharyngioma- German multicenter study on preoperative risk factors and quality of life. Klin. Padiatr. 213,244-249.
42. Müller, H. L., Emser, A., Faldum, A., Bruhnken, G., Etavard-Goris, N., Gebhardt, U., Oeverink, R., Kolb, R., and Sörensen, N. (2004a). Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J. Clin. Endocrinol. Metab. 89, 3298-3305.
43. Müller, H. L., Gebhardt, U., Etavard-Gorris, N., Korenke, E., Warmuth-Metz, M., Kolb, R., Sörensen, N., and Calaminus, G. (2004b). Prognosis and sequela in patients with childhood craniopharyngioma - results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000. Klin. Padiatr. 216, 343-348.
44. Müller, H. L., Faldum, A., Etavard-Gorris, N., Gebhardt, U., Oeverink, R., Kolb, R., and Sörensen, N. (2003a). Functional capacity, obesity and hypothalamic involvement -crosssectional study on 212 patients with childhood craniopharyngioma. Klin. Padiatr. 215, 310-314.
45. Müller, H. L., Heinrich, M., Bueb, K., Etavard-Gorris, N., Gebhardt, U., Kolb, R., and Sörensen, N. (2003b). Perioperative dexamethasone treatment in childhood craniopharyngioma-influence on short-term and long-term weight development. J. Exp. Clin. Endocrinol. Diabetes 111, 330-334.
46. Müller, H. L., Kaatsch, P., Warmuth-Metz, M., Flentje, M., and Sörensen, N. (2003c). Childhood craniopharyngioma - diagnostic and therapeutic strategies. Monatsschr. Kinderheilkd. 151,1056-1063.
47. Müller, H. L., Schneider, P., Etavard-Gorris, N., Gebhardt, U., Kolb, R., and Sörensen, N. (2003d). Volumetric bone mineral density (BMD) in patients with childhood craniopharyngioma. Exp. Clin. Endocrinol. Diabetes 111,168-173.
48. Müller, H. L., Gebhardt, U., Maroske, J., and Hanisch, E. (2011a). Long-term follow-up of morbidly obese patients with childhood craniopharyngioma after laparoscopic adjustable gastric banding (LAGB). Klin. Padiatr. 223, 372-373.
49. Müller, H. L., Gebhardt, U., Teske, C., Faldum, A., Zwiener, I., Warmuth-Metz, M., Pietsch, T., Pohl, F., Sörensen, N., and Calaminus, G. (2011b). Post-operative hypothala-mic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur. J. Endocrinol. 165,17-24.
50. Müller, H. L., Gebhardt, U., Schröder, S., Pohl, F., Kortmann, R.-D., Faldum, A., Zwiener, I., Warmuth-Metz, M., Pietsch, T., Calaminus, G., Kolb, R., Wiegand, C., and Sörensen, N. (2010). Analyses of treatment variables for patients with childhood craniopharyngioma -results of the multicenter prospective study trial KRANIOPHARYNGEOM 2000 after three years of follow up. Horm. Res. Paediatr. 73, 175-180.
51. Müller, H. L., Gebhardt, U., Wes-sel, V., Schröder, S., Kolb, R., Sörensen, N., Maroske, J., and Hanisch, E. (2007). First experiences with laparoscopic gastric banding (LAGB) in the treatment of obese patients with childhood craniopharyngioma. Klin. Padiatr. 219, 323-325.
52. Müller, H. L., Handwerker, G., Wollny, B., Faldum, A., and Sörensen, N. (2002). Melatonin secretion and increased sleepiness in childhood craniopharyngioma. J. Clin. Endocrinol. Metab. 87, 3993-3996.
53. Müller, H. L., and Sörensen, N. (2007). KRANIOPHARYNGEOM 2007 - Prospektive, multizentrische, Untersuchung von Kindern und Jugendlichen mit Kraniopharyngeom. Universitätsverlag Aschenbeck & Isensee, Oldenburg.
54. Müller-Scholden, J., Lehrnbecher, T., Müller, H. L., Bensch, J., Hen-gen, R. H., Sörensen, N., and von Stockhausen, H. B. (2001). Radical surgery in a neonate with craniopharyngioma. Pediatr. Neurosurg. 33,265-269.
55. Nielsen, E. H., Feldt-Rasmussen, U., Poulsgaard, L.,Kristensen, L. O., Astrup, J., Jørgensen, J. O., Bjerre, P., Andersen, M., Andersen, C., Jørgensen, J., Lindholm, J., and Laurberg, P. (2011). Incidence of craniopharyngioma in Denmark (n=189) and estimated world incidence of craniopharyngioma in children and adults. J. Neurooncol. 104, 755-763.
56. Pierre-Kahn, A., Recassens, C., Pinto, G., Thalassinos, C., Chokron, S., Sou-bervielle, J. C., Brauner, R., Zerah, M., and Sainte-Rose, C. (2005). Social and psycho-intellectual outcome following radical removal of craniopharyngiomas in childhood. A prospective series. Childs Nerv. Syst. 21,817-824.
57. Puget, S., Garnett, M., Wray, A., Grill, J., Habrand, J. L., Bodaert, N., Zerah, M., Bezerra, M., Renier, D., Pierre-Kahn, A., and Sainte-Rose, C. (2007). Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothal-amic involvement.J. Neurosurg. 106, 3-12.
58. Puget, S., Grill, J., Habrand, J. L., and Sainte-Rose, C. (2006). Multi-modal treatment of craniopharyngioma: defining a risk-adapted strategy. J. Pediatr. Endocrinol. Metab. 19(Suppl. 1), 367-370.
59. Rajan, B., Ashley, S., Gorman, C., Jose, C. C., Horwich, A., Bloom, H. J. G., Marsh, H., and Brada, M. (1993). Craniopharyngioma -long-term results following limited surgery and radiotherapy. Radiother. Oncol. 26, 1-10.
60. Regine, W. F., and Kramer, S. (1992). Pediatric craniopharyngiomas: long term results of combined treatment with surgery and radiation. Int. J. Radiat. Oncol. Biol. Phys. 24, 611-617.
61. Riva, D., Pantaleoni, C., Devoti, M., Saletti, V., Nichelli, F., and Giorgi, C. (1998). Late neuropsychological and behavioural outcome of children surgically treated for cranio-pharyngeoma. Childs Nerv. Syst. 14, 179-184.
62. Roth, C., Gebhardt, U., and Müller, H. L. (2011). Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity (Silver Spring) 19, 36-41.
63. Roth, C., Hunneman, D., Gebhardt, U., Stoffel-Wagner, B., Reinehr, T., and Müller, H. L. (2007). Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma. Pediatr. Res. 61,496-501.
64. Roth, C., Wilken, B., Hanefeld, F., Schröter, W., and Leonhardt, U. (1998). Hyperphagia in children with craniopharyngioma is associated with hyperleptinemia and a failure in the down regulation of appetite. Eur. J. Endocrinol. 138, 89-91.
65. Roth, C. L., Enriori, P. J., Gebhardt, U., Hinney, A., Müller, H. L., Hebe-brand, J., Reinehr, T., and Cowley, M. A. (2010). Changes of peripheral alpha-melanocyte-stimulating hormone in childhood obesity. Metab. Clin. Exp. 59,186-194.
66. Rushing, E. J., Giangaspero, F., Paulus, W., and Burger, P. C. (2007). "Craniopharyngioma," in WHO Classification of Tumours of the Central Nervous System, eds D. N. Louis, H. Ohgaki, O. D. Wiestler, and W. K. Cavanee (Lyon: IARC Press), 238-240.
67. Sanford, R. A. (1994). Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery. Pediatr. Neurosurg. 21(Suppl. 1), 39-43.
68. Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., and Stewart, P. M. (2010). Mortality in patients with pituitary disease. Endocr.Rev. 31,301-342.
69. Srinivasan, S., Ogle, G. D., Garnett, S. P., Briody, I. N., Lee, J. W., and Cowell, C. T. (2004). Features of the metabolic syndrome after childhood craniopharyngioma. J. Clin. Endocrinol. Metab. 89, 81-86.
70. Stripp, D. C., Maity, A., Janss, A. J., Belasco, J. B., Tochner, Z. A., Gold-wein, J. W., Moshang, T., Rorke, L. B., Phillips, P. C., Sutton, L. N., and Shu, H. K. (2004). Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int. J. Radiat. Oncol. Biol. Phys. 58, 714-720.
71. Tomita, T., and Bowman, R. M. (2005). Craniopharyngiomas in children: surgical experience at Children's Memorial Hospital. Childs Nerv. Syst. 21,729-746.
72. Warmuth-Metz, M., Gnekow, A., Müller, H. L., and Sörensen, N. (2004). Differential diagnosis of suprasellar tumors in children. Klin. Padiatr. 216,323-330.
73. Wolff, J. E., Daumling, E., Dirksen, A., Dabrock, A., Hartmann, M., and Jür-gens, H. (1996). Münster Heidelberg abilities scale - a measuring instrument for global comparison of illness sequelae. Klin. Padiatr. 208, 294-298.
74. Yasargil, M. G., Curcic, M., Kis, M., Siegenthaler, G., Teddy, P. J., and Roth, P. (1990). Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J. Neurosurg. 73, 3-11